Aarvik Therapeutics

Recent Finacing

Seed II

Recent Raise

Undisclosed

Aarvik Therapeutics is a Hayward-based biotechnology company developing next-generation antibody-drug conjugates (ADCs) for cancer using its proprietary MUTTA platform.

California, United States

11-50

Private

aarviktx.com

Highlights

Focus Areas

Biotechnology

Life Science

Oncology

Recent Investors

Financials

2

Funding rounds

1

Investor

Team

Upgrade to view the team

See the team members at Aarvik Therapeutics.